Sapphire II Pro 220-203-5UURecalls & reported problems
OrbusNeich Medical (ShenZhen) Co., Ltd. · Balloon Dilatation Catheter · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 06934955942198), received between Mar 26, 2026 and Mar 26, 2026 — classified as 2 injuries.
The most frequently reported specific device problem is “Material Separation” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Material Separation2
Patient problems
- Foreign Body In Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryMar 26, 2026Material Separation
IT WAS REPORTED THAT A SAPPHIRE II BALLOON CAME APART AT DISTAL AREA OF BALLOON. FIRST ADDITIONAL INFORMATION WAS RECEIVED ON 03/04/2026: 1. PROVIDE A DETAILED SUMMARY OF EVENT FROM BEGINNING TO END, INCLUDING TROUBLESHOOTING AND RESOLUTION. - WAITING ON EMAIL FROM HOSPITAL. 2. ANATOMICAL INFORMATION? (VESSEL / LOCATION / TORTUOSITY / CALCIFICATION / STENOSIS % / ETC.) - UNKNOWN. 3. PLEASE PROVIDE PATIENT DEMOGRAPHICS (GENDER, AGE, WEIGHT, RACE, ETHNICITY) AND COMORBIDITIES. IF UNAVAILABLE, PLEASE PROVIDE REASON WHY (E.G. HOSPITAL PRIVACY POLICY) - I THOUGHT I CHOSE THE HOSPITAL PRIVATE POLICY. 4. DID THE BALLOON BECOME FULLY DETACHED OR WAS IT DAMAGED INTACT? - IT LOOKS LIKE IT'S DETACHED. 5. HOW WAS THE BALLOON FRAGMENT(S) REMOVED FROM THE PATIENT? - HE REMAINS WITH A WALL STENT COVERING. 6. IF FRAGMENT(S) REMAIN IN VIVO - DOES THE PHYSICIAN HAVE ANY CONCERNS ABOUT POTENTIAL LONG-TERM RISK OUTCOMES? - THE HOSPITAL SHOULD BE SENDING INFORMATION. 7. WHAT IS THE STATUS OF THE PATIENT? - UNKNOWN. SECOND ADDITIONAL INFORMATION WAS RECEIVED ON 3/13/2026: 1. PROVIDE A DETAILED SUMMARY OF EVENT FROM BEGINNING TO END, INCLUDING TROUBLESHOOTING AND RESOLUTION. - IT SEEMS THEY WERE USING TH
Patient problems: Foreign Body In Patient
MAUDE report 24696400 ↗InjuryMar 26, 2026Material Separation
IT WAS REPORTED THAT A SAPPHIRE II BALLOON CAME APART AT DISTAL AREA OF BALLOON. FIRST ADDITIONAL INFORMATION WAS RECEIVED ON 3/4/2026: 1. PROVIDE A DETAILED SUMMARY OF EVENT FROM BEGINNING TO END, INCLUDING TROUBLESHOOTING AND RESOLUTION. WAITING ON EMAIL FROM HOSPITAL. 2. ANATOMICAL INFORMATION? (VESSEL / LOCATION / TORTUOSITY / CALCIFICATION / STENOSIS % / ETC.) UNKNOWN. 3. PLEASE PROVIDE PATIENT DEMOGRAPHICS (GENDER, AGE, WEIGHT, RACE, ETHNICITY) AND COMORBIDITIES. IF UNAVAILABLE, PLEASE PROVIDE REASON WHY (E.G. HOSPITAL PRIVACY POLICY) I THOUGHT I CHOSE THE HOSPITAL PRIVATE POLICY. 4. DID THE BALLOON BECOME FULLY DETACHED OR WAS IT DAMAGED INTACT? IT LOOKS LIKE IT'S DETACHED. 5. HOW WAS THE BALLOON FRAGMENT(S) REMOVED FROM THE PATIENT? HE REMAINS WITH A WALL STENT COVERING. 6. IF FRAGMENT(S) REMAIN IN VIVO - DOES THE PHYSICIAN HAVE ANY CONCERNS ABOUT POTENTIAL LONG-TERM RISK OUTCOMES? THE HOSPITAL SHOULD BE SENDING INFORMATION. 7. WHAT IS THE STATUS OF THE PATIENT? UNKNOWN. SECOND ADDITIONAL INFORMATION WAS RECEIVED ON 3/13/2026: 1. PROVIDE A DETAILED SUMMARY OF EVENT FROM BEGINNING TO END, INCLUDING TROUBLESHOOTING AND RESOLUTION. IT SEEMS THEY WERE USING THIS IN A MINE CORON
Patient problems: Foreign Body In Patient
MAUDE report 24696380 ↗
Other Catheters, Transluminal Coronary Angioplasty, Percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page